Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Plasma exchange (PE) vs sham exchange Adverse events ‐ not reported · people with IgG and IgA paraproteinaemic neuropathy Treatment for IgG and IgA paraproteinaemic neuropathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR ASAS partial remission TNF‐alpha inhibitors for ankylosing spondylitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Radiographic progression TNF‐alpha inhibitors for ankylosing spondylitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Withdrawals due to adverse events TNF‐alpha inhibitors for ankylosing spondylitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Serious adverse events TNF‐alpha inhibitors for ankylosing spondylitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Healthcare outcomes · healthcare professionals Tailored interventions to address determinants of practice (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · healthcare professionals Tailored interventions to address determinants of practice (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects · healthcare professionals Tailored interventions to address determinants of practice (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of type 2 diabetes mellitus · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Diabetic complications · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Distant consultancy · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Generic waiting list · patients needing elective specialist ambulatory visit or surgery Interventions to reduce waiting times for elective procedures (2015) · Cochrane | no estimate extracted | NR | No studies |
TEMPOROPARIETAL TMS vs STANDARD TREATMENT Mental state ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
TEMPOROPARIETAL TMS vs STANDARD TREATMENT Cognitive state ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
TEMPOROPARIETAL TMS vs STANDARD TREATMENT Adverse effects: general or specific ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
TEMPOROPARIETAL TMS vs STANDARD TREATMENT Satisfaction with care ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PREFRONTAL TMS vs SHAM TMS Clinical improvement in global state ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PREFRONTAL TMS vs SHAM TMS Satisfaction with care ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PREFRONTAL TBS TMS vs SHAM TMS Global state score ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
PREFRONTAL TBS TMS vs SHAM TMS Satisfaction with care ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
TEMPOROPARIETAL TMS vs SHAM TMS Satisfaction with care ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
TEMPOROPARIETAL TMS vs STANDARD TREATMENT Global state score ‐ not reported · people with schizophrenia Transcranial magnetic stimulation (TMS) for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
Brochure and an audiotape vs standard care Rate of congenital toxoplasmosis defined by persistence of IgG antibodies beyond 11 months · women of reproductive age, irrespective of their pregnant status Prenatal education for congenital toxoplasmosis (2015) · Cochrane | no estimate extracted | NR | No studies |
Brochure and an audiotape vs standard care Pregnant women knowledge of risk factors for acquiring toxoplasmosis infection as objectively measured through specific questionnaire · women of reproductive age, irrespective of their pregnant status Prenatal education for congenital toxoplasmosis (2015) · Cochrane | no estimate extracted | NR | No studies |
Brochure and an audiotape vs standard care Pregnant women awareness of the importance of avoiding toxoplasmosis infection during pregnancy as objectively measured through specific questionnaire · women of reproductive age, irrespective of their pregnant status Prenatal education for congenital toxoplasmosis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR BCMA vs no BCMA Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR aPrescriptions. Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR CPOE vs no CPOE Interventions for reducing medication errors in children in hospital (2015) · Cochrane | no estimate extracted | NR | No studies |
MMC vs 5‐FU Quality of life at 1 year · wound healing in glaucoma surgery Mitomycin C versus 5‐Fluorouracil for wound healing in glaucoma surgery (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table: photocoagulation of drusen vs control Outcomes at two years Laser treatment of drusen to prevent progression to advanced age‐related macular degeneration (2015) · Cochrane | no estimate extracted | NR | No studies |
Split‐course radiotherapy (8 fractions, 30 Gy) vs short‐course radiotherapy (2 fractions, 16 Gy) Quality of life · adults with metastatic extradural spinal cord compression (poor prognosis, no spinal instability or bony impingement… Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Laminectomy plus radiotherapy vs radiotherapy Local recurrence · adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery) Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Laminectomy plus radiotherapy vs radiotherapy Quality of life · adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery) Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Decompressive surgery plus radiotherapy vs radiotherapy Local recurrence · adults with metastatic extradural spinal cord compression (fit for surgery, paraplegic less than 48 hours, and without… Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Decompressive surgery plus radiotherapy vs radiotherapy Quality of life · adults with metastatic extradural spinal cord compression (fit for surgery, paraplegic less than 48 hours, and without… Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
High‐dose corticosteroids vs moderate‐dose or no corticosteroids Local recurrence ‐ · adults with metastatic extradural spinal cord compression (without peptic ulceration or infection; mixed prognosis) Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
High‐dose corticosteroids vs moderate‐dose or no corticosteroids Quality of life · adults with metastatic extradural spinal cord compression (without peptic ulceration or infection; mixed prognosis) Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Single‐fraction radiotherapy (8 Gy) vs short‐course radiotherapy (16 Gy Quality of life · adults with metastatic extradural spinal cord compression (poor prognosis with visceral metastasis, and no spinal… Interventions for the treatment of metastatic extradural spinal cord compression in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Healthcare utilisation Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health outcomes Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs Pharmaceutical policies: effects of financial incentives for prescribers (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR PEI versus PAI · hospitalised people with early HCC treated with PEI, PAI, or surgery. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Number and type of adverse events · hospitalised people with early HCC treated with PEI, PAI, or surgery. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life · hospitalised people with early HCC treated with PEI, PAI, or surgery. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR PEI versus surgery · hospitalised people with early HCC treated with PEI, PAI, or surgery. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma (2015) · Cochrane | no estimate extracted | NR | No studies |
Long protocol (continued same vs reduced dose GnRHa) Live birth and ongoing pregnancies per woman randomised · women undergoing pituitary suppression in assisted reproduction Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction (2015) · Cochrane | no estimate extracted | NR | No studies |